FDA Approves First One-Time Treatment for RDEB Wounds ...Middle East

Medscape - News
FDA Approves First One-Time Treatment for RDEB Wounds
In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, compared with 16% in matched control wounds treated with standard of care. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First One-Time Treatment for RDEB Wounds )

Apple Storegoogle play

Also on site :



Latest News